Preventing Cancers of the Upper Aerodigestive Tract: Challenges for
Clinicians
Ellen R. Gritz, Ph.D.
Professor and Chair, Department of Behavioral Science
Alexander V. Prokhorov, M.D., Ph.D.
Assistant Professor,Department of Behavioral Science
Cancers of the upper aerodigestive tract significantly contribute to
cancer-related morbidity and mortality in the United States (an estimated 52,900
new cases and 24,500 deaths in 1999 alone). From the early 1970s to the early
1990s, the death rates from esophageal cancer increased 24% among men and 7%
among women.
The use of tobacco and alcohol are considered to be the most important risk
factors for these cancers (oral cavity, pharynx, larynx, and esophagus). Studies
have shown that alcohol and tobacco appear to be independent and synergistic
risk factors. Consumption of tobacco and alcohol are frequently concomitant
behaviors; tobacco use is higher among those who drink alcohol, and the
consumption of alcohol is higher among tobacco users.
Findings from a French investigation suggest that even heavy smokers may
reduce their risk of cancer by quitting smoking.
Clinicians are in an excellent position to help their patients quit smoking,
but to do so effectively requires familiarity with the basic principles of
smoking cessation counseling and pharmacological treatment. Nicotine gum and
patches have been proven to increase smoking cessation rates by 60% and 100%,
respectively. The nicotine inhaler and nasal spray are also now available by
prescription, and the Food and Drug Administration has recently approved the
smoking cessation drug bupropion.
This year, a revised edition of The Smoking Cessation Clinical Practice
Guideline, which summarizes the most effective methods of treating nicotine
dependence, will be published by the Agency for Healthcare Research and Quality
(AHRQ), and we highly recommend that every clinician become familiar with it.
The guideline urges clinicians to follow five steps: (1) systematically identify
all smokers; (2) strongly advise all smokers to quit; (3) determine a smoker's
willingness to quit; (4) motivate smokers who are not willing to quit smoking
immediately and assist those who are willing to quit by having them set a quit
date, offering pharmacological quitting aids, and providing self-help materials
and skill training; and (5) schedule a follow-up contact. More information about
the AHRQ guideline can be found on the World Wide Web (http://www.ahcp
r.gov/research/apr96/dept8.htm).
Helping patients stop smoking is the single most important step physicians
can take to reduce the burden of cancer mortality.
M. D. ANDERSON ONCOLOG
Volume 45, Number 4 (April 2000)
Copyright 2000 The University of Texas M. D. Anderson Cancer Center, Houston,
Texas
|